Nestlé is the latest company to join the lucrative world of Ozempic. It’s launching a new line of frozen food created with users of GLP-1 agonist medications in mind.

Glucagon-like peptide-1 agonist drugs have been surging in popularity, and manufacturers are scurrying to keep up with demand. Overall, the GLP-1 market is expected to experience annual growth ...

Hims & Hers aims to capitalize on the shortages of the branded drugs Wegovy and Zepbound. Read more to see why I'm bullish on ...

One in eight adults (12 percent) say they have ever taken a glucagon-like peptide-1 receptor agonist (GLP-1 RA) and 6 percent say they are currently using one, ...

Only 14.5% of adult patients with moderate or severe asthma are prescribed the recommended SMART combination inhaler regimen ...

While Eli Lilly and Novo Nordisk currently dominate the GLP-1 receptor agonist space, there are more than 50 candidates in ...

The majority — 62 percent — said they were using the drugs to treat a chronic condition like diabetes or heart disease while ...

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of incretin mimetic medicines for the treatment of Type 2 ...

Viking Therapeutics' (VKTX) lead candidate for obesity, VK2735, is expected to have tremendous potential. However, existing ...

In the majority of IVF cycles, whether using an agonist or an antagonist protocol, the trigger used is human chorionic gonadotropin (hCG), which shares a common subunit with LH and thus acts as a ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced positive results from the Phase Ib ...